The action of Pdcd4 may be cell type specific: Evidence that reduction of dUTPase levels might contribute to its tumor suppressor activity in Bon-1 cells

Apoptosis

Volumn 13, Issue 1, 2008, Pages 157-164

  Lankat Buttgereit, Brigitte ^a   Lenschen, Barbara ^a   Schmidt, Harald ^a   Göke, Rüdiger ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Pdcd4; Regulation of proteins; Tumor suppressor

Indexed keywords

COMPLEMENTARY DNA; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; FARNESOL; FLUOROURACIL; PROGRAMMED CELL DEATH PROTEIN 4; PROTEIN; THYMIDYLATE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRAIN HCT116; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PDCD4 GENE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FLUOROURACIL; HUMANS; PYROPHOSPHATASES; RNA-BINDING PROTEINS; TRANSFECTION;

EID: 38049113224     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0153-x     Document Type: Article

References (38)

1. Göke A, Göke R, Knolle A et al (2002) DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem Biophys Res Commun 297(1):78-82
2. Shibahara K, Asano M, Ishida Y et al (1995) Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166(2):297-301
3. Onishi Y, Kizaki H (1996) Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. Biochem Biophys Res Commun 228(1):7-13
4. Matsuhashi S, Yoshinaga H, Yatsuki H, Tsugita A, Hori K (1997) Isolation of a novel gene from a human cell line with Pr-28 MAb which recognizes a nuclear antigen involved in the cell cycle. Res Comm Biochem Cell Mol Biol 1(1):109-120
5. Azzoni L, Zatsepina O, Abebe B et al (1998) Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol 161(7):3493-3500
6. Schlichter U, Burk O, Worpenberg S, Klempnauer KH (2001) The chicken Pdcd4 gene is regulated by v-Myb. Oncogene 20(2):231-239
7. Appl H, Klempnauer KH (2002) Targeted disruption of c-myb in the chicken pre B-cell line DT40. Oncogene 21(19):3076-3081
8. Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH (2004) Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23(49):8135-8145
9. Jansen AP, Camalier CE, Stark C, Colburn NH (2004) Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 3(2):103-110
10. Zhang H, Ozaki I, Mizuta T et al (2006) Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 8:8
11. Cmarik JL, Min H, Hegamyer G et al (1999) Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 96(24):14037-14042
12. Yang HS, Jansen AP, Nair R et al (2001) A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 20(6):669-676
13. Jansen AP, Camalier CE, Colburn NH (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65(14):6034-6041
14. Yang HS, Jansen AP, Komar AA et al (2003) The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23(1):26-37
15. Lankat-Buttgereit B, Gregel C, Knolle A et al (2004) Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol Cell Endocrinol 214(1-2):149-153
16. Onishi Y, Hashimoto S, Kizaki H (1998) Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 215(2):453-459
17. Chen Y, Knosel T, Kristiansen G et al (2003) Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200(5):640-646
18. Carinci F, Lo Muzio L, Piattelli A et al (2005) Potential markers of tongue tumor progression selected by cDNA microarray. Int J Immunopathol Pharmacol 18(3):513-524
19. Yang HS, Knies JL, Stark C, Colburn NH (2003) Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22(24):3712-3720
20. Zhang Y, Ohyashiki JH, Takaku T, Shimizu N, Ohyashiki K (2006) Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection. Br J Cancer 94(4):599-608
21. Hammerl P, Hartl A, Thalhamer J (1993) Particulate nitrocellulose as a solid phase for protein immobilization in immuno-affinity chromatography. J Immunol Methods 165(1):59-66
22. Diettrich O, Gallert F, Hasilik A (1996) Purification of lysosomal membrane proteins from human placenta. Eur J Cell Biol 69(2):99-106
23. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20(18):3551-3567
24. Göke R, Barth P, Schmidt A, Samans B, Lankat-Buttgereit B (2004) Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol 287(6):C1541-C1546. Epub 2004 Aug 18
25. Yang HS, Matthews CP, Clair T et al (2006) Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26(4):1297-1306
26. Yoshinaga H, Matsuhashi S, Fujiyama C, Masaki Z (1999) Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody. Pathol Int 49(12):1067-1077
27. Matsuhashi S, Watanabe T, Hori K (1987) An antigen expressed in proliferating cells at late G1-S phase. Exp Cell Res 170(2):351-362
28. Kang MJ, Ahn HS, Lee JY, Matsuhashi S, Park WY (2002) Up-regulation of PDCD4 in senescent human diploid fibroblasts. Biochem Biophys Res Commun 293(1):617-621
29. Böhm M, Sawicka K, Siebrasse JP et al (2003) The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 22(31):4905-4910
30. Yoshinaga H, Matsuhashi S, Ahanek J, Masaki Z, Hori K (1997) Expression and identification of H731 gene product in HeLa cells. Res Commun Biochem Cell Mol Biol 1:121-131
31. Göke R, Gregel C, Göke A et al (2004) Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells. Ann N Y Acad Sci 1014:220-221
32. Ladner RD, Carr SA, Huddleston MJ, McNulty DE, Caradonna SJ (1996) Identification of a consensus cyclin-dependent kinase phosphorylation site unique to the nuclear form of human deoxyuridine triphosphate nucleotidohydrolase. J Biol Chem 271(13):7752-7757
33. Grasser FA, Romeike BF, Niedobitek G, Nicholls J, Kremmer E (2001) dUTPase in human neoplastic cells as a potential target for therapeutic intervention. Curr Protein Pept Sci 2(4):349-360
34. Canman CE, Lawrence TS, Shewach DS, Tang HY, Maybaum J (1993) Resistance to fluorodeoxyuridine-induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate. Cancer Res 53(21):5219-5224
35. Fleischmann J, Kremmer E, Muller S et al (1999) Expression of deoxyuridine triphosphatase (dUTPase) in colorectal tumours. Int J Cancer 84(6):614-617
36. Ladner RD, Lynch FJ, Groshen S et al (2000) dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer. Cancer Res 60(13):3493-3503
37. Koehler SE, Ladner RD (2004) Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition. Mol Pharmacol 66(3):620-626
38. Mo H, Elson CE (2004) Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 229(7):567-585